What is Kymera Therapeutics, Inc. Common Stock's Market Cap?

Kymera Therapeutics, Inc. Common Stock's Market Cap is $9.7B, based on as-reported figures from SEC (XBRL) filings.

What is Kymera Therapeutics, Inc. Common Stock's Enterprise Value?

Kymera Therapeutics, Inc. Common Stock's Enterprise Value is $9.6B, based on as-reported figures from SEC (XBRL) filings.

What is Kymera Therapeutics, Inc. Common Stock's Price / Sales?

Kymera Therapeutics, Inc. Common Stock's Price / Sales is 92.2×, based on as-reported figures from SEC (XBRL) filings.

What is Kymera Therapeutics, Inc. Common Stock's EV / Revenue?

Kymera Therapeutics, Inc. Common Stock's EV / Revenue is 91.1×, based on as-reported figures from SEC (XBRL) filings.

What is Kymera Therapeutics, Inc. Common Stock's EV / EBITDA?

Kymera Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Kymera Therapeutics, Inc. Common Stock's Revenue (TTM)?

Kymera Therapeutics, Inc. Common Stock's Revenue (TTM) is $105.0M, based on as-reported figures from SEC (XBRL) filings.

What is Kymera Therapeutics, Inc. Common Stock's Net Income (TTM)?

Kymera Therapeutics, Inc. Common Stock's Net Income (TTM) is -$299.6M, based on as-reported figures from SEC (XBRL) filings.

What is Kymera Therapeutics, Inc. Common Stock's EBITDA?

Kymera Therapeutics, Inc. Common Stock's EBITDA is -$341.9M, based on as-reported figures from SEC (XBRL) filings.

What is Kymera Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Kymera Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.60, based on as-reported figures from SEC (XBRL) filings.

What is Kymera Therapeutics, Inc. Common Stock's EBITDA Margin?

Kymera Therapeutics, Inc. Common Stock's EBITDA Margin is -325.7%, based on as-reported figures from SEC (XBRL) filings.

Kymera Therapeutics, Inc. Common Stock (KYMR) Financial Statements

Kymera Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00SDHC8F9

XNAS · usd

116.47▼ 0.92 (-0.78%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close117.39

Day's Range113.97 – 120.22

52-Week Range42.22 – 130.05

Volume631.3K

Avg Volume653.2K

Share Statistics

Shares Outstanding

Employees238

ExchangeXNAS

Listed2020-08-21

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Kymera Therapeutics, Inc. Common Stock (KYMR)

What is Kymera Therapeutics, Inc. Common Stock's Market Cap?: Kymera Therapeutics, Inc. Common Stock's Market Cap is $9.7B, based on as-reported figures from SEC (XBRL) filings.
What is Kymera Therapeutics, Inc. Common Stock's Enterprise Value?: Kymera Therapeutics, Inc. Common Stock's Enterprise Value is $9.6B, based on as-reported figures from SEC (XBRL) filings.
What is Kymera Therapeutics, Inc. Common Stock's Price / Sales?: Kymera Therapeutics, Inc. Common Stock's Price / Sales is 92.2×, based on as-reported figures from SEC (XBRL) filings.
What is Kymera Therapeutics, Inc. Common Stock's EV / Revenue?: Kymera Therapeutics, Inc. Common Stock's EV / Revenue is 91.1×, based on as-reported figures from SEC (XBRL) filings.
What is Kymera Therapeutics, Inc. Common Stock's EV / EBITDA?: Kymera Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Kymera Therapeutics, Inc. Common Stock's Revenue (TTM)?: Kymera Therapeutics, Inc. Common Stock's Revenue (TTM) is $105.0M, based on as-reported figures from SEC (XBRL) filings.
What is Kymera Therapeutics, Inc. Common Stock's Net Income (TTM)?: Kymera Therapeutics, Inc. Common Stock's Net Income (TTM) is -$299.6M, based on as-reported figures from SEC (XBRL) filings.
What is Kymera Therapeutics, Inc. Common Stock's EBITDA?: Kymera Therapeutics, Inc. Common Stock's EBITDA is -$341.9M, based on as-reported figures from SEC (XBRL) filings.
What is Kymera Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Kymera Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.60, based on as-reported figures from SEC (XBRL) filings.
What is Kymera Therapeutics, Inc. Common Stock's EBITDA Margin?: Kymera Therapeutics, Inc. Common Stock's EBITDA Margin is -325.7%, based on as-reported figures from SEC (XBRL) filings.